- Report
- January 2024
- 100 Pages
Africa
From €1909EUR$2,000USD£1,599GBP
- Report
- January 2024
- 80 Pages
Vietnam
From €1432EUR$1,500USD£1,199GBP
- Report
- January 2024
- 80 Pages
Russia
From €1432EUR$1,500USD£1,199GBP
- Report
- January 2024
- 80 Pages
Poland
From €1432EUR$1,500USD£1,199GBP
- Report
- January 2024
- 80 Pages
Japan
From €1432EUR$1,500USD£1,199GBP
- Report
- January 2024
- 80 Pages
Ireland
From €1432EUR$1,500USD£1,199GBP
- Report
- January 2024
- 80 Pages
Brazil
From €1432EUR$1,500USD£1,199GBP
- Report
- January 2024
- 80 Pages
Argentina
From €1432EUR$1,500USD£1,199GBP
- Report
- January 2025
- 132 Pages
Global
From €907EUR$950USD£760GBP
- Report
- January 2025
- 132 Pages
Global
From €907EUR$950USD£760GBP
- Report
- January 2025
- 132 Pages
Global
From €907EUR$950USD£760GBP
- Report
- July 2024
- 280 Pages
Global
From €2534EUR$2,655USD£2,123GBP
- Report
- July 2024
- 216 Pages
Global
From €2534EUR$2,655USD£2,123GBP
- Report
- February 2022
- 229 Pages
Global
From €3543EUR$3,712USD£2,968GBP

The Chemiluminescence Immunoassay (CLIA) market is a segment of the In Vitro Diagnostics (IVD) industry. CLIA is a type of immunoassay that uses a chemical reaction to detect the presence of a specific antigen or antibody in a sample. CLIA tests are used to diagnose a wide range of medical conditions, including infectious diseases, autoimmune disorders, and cancer. CLIA tests are highly sensitive and specific, and can be used to detect very low levels of antigens or antibodies in a sample.
CLIA tests are used in a variety of healthcare settings, including hospitals, clinics, and laboratories. CLIA tests are also used in research and development, as well as in the food and beverage industry. CLIA tests are becoming increasingly popular due to their accuracy and cost-effectiveness.
Some companies in the CLIA market include Abbott Laboratories, Beckman Coulter, Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific. Show Less Read more